Cagle, PhD, Research Scientist, Perspective Therapeutics Presentation Two: Impact of molar activity on [ 203 Pb]Pb-VMT-α-NET biodistribution profile in mice bearing neuroendocrine tumor xenograft ...

There’s no denying it: the radiopharmaceuticals boom is here to stay. | Telix on Tuesday unveiled the spin-off of Rhine ...

Namibia is seeking to harness nuclear science and technology to boost its socio-economic development with a particular focus on energy healthcare an ...

Mediso is unveiling its new AnyScan® TRIO SPECT/CT, TheraMAX* scanner at the annual meeting of European Association of ...

Bicycle Therapeutics (BCYC) announced the presentation of the first human imaging data validating the potential of MT1-MMP as a novel target in ...

The McGill University Health Centre (MUHC) is proud to announce the opening of its newly renovated Nuclear Medicine unit at ...

Molybdenum-99 Market. The global molybdenum-99 market is poised for substantial growth, with estimates predicting its value ...

A new PET scan reliably detects benign tumors in the pancreas, according to research led by Radboud university medical center ...

Ac-Satoreotide is a first-in-class somatostatin receptor 2 antagonist targeting extensive stage small cell lung cancer and is the first antagonist labelled with 225Ac to enter clinical ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the spin-off of Rhine Pharma[1], which has the ...

DMedical Ltd (ASX:4DX) has been awarded $1.9 million from the Federal Government under the latter’s CRC-P (Cooperative ...

LSS imaging allows mapping these histological properties over wide areas of epithelial lining. Because nuclear enlargement, pleomorphism and hyperchromasia are principal features of nuclear atypia ...